Cytokinetics Inc. buy Truist Financial Co.
Start price
28.12.23
/
50%
€76.00
Target price
28.12.24
€77.64
Performance (%)
-31.58%
Price
04.10.24
€52.00
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ for Cytokinetics Inc. is performing very badly with a performance of -31.58%. This prediction currently runs until 28.12.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cytokinetics Inc. | 10.638% | 10.638% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target raised by analysts at Truist Financial Co. from $60.00 to $86.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€45.00
29.05.24
29.05.24
€64.57
29.05.25
29.05.25
15.56%
04.10.24
04.10.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€68.00
08.04.24
08.04.24
€79.21
08.04.25
08.04.25
-23.53%
04.10.24
04.10.24